Agasthi Premium-S filler 10ml

PREMIUM-S is formulated for soft volume enhancement and natural body contouring. Its high tissue integration supports smooth transitions and refined shaping.

Professional Use


10mL pre-filled syringe x 1ea


Hyaluronic Acid 20mg/mL
8 – 12 Months

A MANUFACTURED FILLER USING HYALURONIC ACID (HA)
 DERIVED FROM FREE ANIMAL SUBSTANCES WITH HIGH PURITY
 TO HAVE BIOCOMPATIBILITY IN HUMAN TISSUE.

HYALURONIC ACID is a component that helps supply water and regenerate cells in the skin.
 

AGASHTI is composed of reticular derivatives of swelling degrees that constantly maintain elasticity inside the body.

“DIFFERENTIATED MANUFACTURING TECHNOLOGY”

Premium Hyaluronic Acid.


Internationally recognized by FDA and EDQM, is being used.

Scientific Foundation

AGASTHI fillers are based on crosslinked hyaluronic acid, engineered to deliver optimized viscoelasticity, cohesion, and tissue integration.

Our development process focuses on balancing lifting capacity, flexibility, and durability while minimizing formulation stress on surrounding tissues.

MSFT

MULTIPLE SWELLING FORMULATION TECHNOLOGY

MSFT is a method of blending multiple swelling ratios, and it maintains excellent volume effects while ensuring safety by minimizing crosslinking agents Minimal use of crosslinking agents.

Minimal use of crosslinking agent

Increase hydrophilicity by blending gels with a different swelling ratio

Safely maintain volume by minimizing crosslinking agent and increasing hydrophilicity

Viscoelasticity

SINCE AGASTHI IS PRODUCED BY MSFT TECHNOLOGY, IT RESULTS IN HIGH TISSUE ADHESION AND EXCELLENT VOLUME EFFECT.

SWELLING RATIO OF FILLERS

AGASTHI is made up of hyaluronic acid gels with a high ratio of hydrophilic that provides an excellent volume effect.

TISSUE ADHESION TACK TEST OF FILLERS

AGASTHI has outstanding tissue adhesion with high cohesion.

Safety Profile

AGASTHI IS AN INNOVATIVE PRODUCT THAT MINIMIZES TOXICITY AND INCREASES SAFETY WITH THE USE OF ITS UNIQUE TECHNOLOGY, MSFT.

AGASTHI minimizes free radical formation by significantly reducing proteins that may cause hypersensitivity reactions.

Moreover, AGASTHI has a low unit level of endotoxin which holds an outstanding safety profile.

IN-VITRO ENZYME SAFETY

The finding from the in-vitro decomposition process substantiates that AGASTHI has 4 times longer body duration than any product.

Injection Force

SYRINGEABILITY TEST

Injection Force

AGASTHI COMBINES ALL THE NECESSARY QUALITIES: SAFETY, EFFICACY, SUSTAINABILITY

Description

Description

Gel Viscoelasticity: Soft Type (Moderate Viscoelasticity)

Rheological Focus: High G’ (Storage Modulus)

AGASTHI PREMIUM-S is designed for structural support and point-based lifting. Acting as a
“pillar-like” filler, it provides strong resistance to deformation in gravity-sensitive anatomical areas.

Primary Indications: Upper breast side, upper arms, and delicate body line smoothing.

Researcher’s Insight:
Focuses on tissue integration and natural texture. The gel is formulated to be supple, mimicking the feel of
natural soft tissue. It spreads evenly without forming lumps, ensuring a seamless transition between the filler
and the patient’s skin.

Specifications

Type: Soft



Main Target: Natural Softness



Area: Nasolabial folds, Jawline, Nose bridge, Forehead lines, Glabella lines, Lips, Breasts, Arms



Technology: MSFT High-Adhesion


Needle size: 21-23G



Duration: 8–12 months

Safe Profile: BDDE < 2ppm

Key Advantage: High hydrophilicity for a natural moisturizing effect and a soft, realistic touch.

Related Products